ReposiTrak Swaps $4M SPAR Note and 8.9M Shares for SPAR Preferred Plus 9.68M-Share Warrant
TRAK is trading near its 52-week low of $6.275 (0.9% above the low) on elevated volume (2.5× avg).
Summary
ReposiTrak exchanged a ~$4.0M SPAR note and 8.9M SPAR shares for SPAR Series C Preferred plus a warrant on 9.68M SPAR shares, and extended SPAR a new $1.5M credit line. The deal turns a receivable and minority stake into a senior, dividend-paying position with anti-dilution protection.
Key Events · Financing and Capital Events · TRAK
-
Note and Shares Swapped for SPAR Preferred
PCG exchanged ~$4.0M of SPAR principal and accrued interest plus 8,900,406 SPAR common shares for 3,360 shares of SPAR Series C Preferred with a $1,000 stated value, convertible at $0.38 per share.
-
Warrant on 9.68M SPAR Shares
SPAR issued ReposiTrak a warrant for 9,684,211 common shares at $0.38, exercisable from January 31, 2028 through January 31, 2032.
-
New $1.5M Revolver to SPAR
ReposiTrak extended SPAR a $1.5M revolving credit facility at 8% interest maturing November 13, 2028, with 50% warrant coverage on direct advances and on sourced third-party financing.
-
Anti-Dilution and 50% Ownership Cap
SPAR must issue additional Series C Preferred to hold ReposiTrak's as-converted percentage steady; conversion and voting are capped at 50% until the cap sunsets December 23, 2027.
Analysis · TRAK · Technology
ReposiTrak is restructuring its exposure to SPAR Group, where it already held a 14.8% stake. The company is converting a roughly $4.0 million note receivable and 8,900,406 SPAR common shares into 3,360 shares of a new SPAR Series C Preferred. That preferred carries an 8% cash dividend (10% if paid in kind) and converts at $0.38 per share. ReposiTrak also receives a warrant for 9,684,211 SPAR shares at $0.38, exercisable from January 31, 2028. The trade converts a fixed receivable and a passive minority stake into a senior, dividend-paying position with anti-dilution protection and a path to majority ownership once the 50% ownership cap sunsets on December 23, 2027. In addition, ReposiTrak extends SPAR a new $1.5 million revolver at 8%, earning 50% warrant coverage on any draws. The risk is concentration: ReposiTrak's balance sheet becomes tied to SPAR's credit, and the value of the preferred and warrant depends on SPAR's equity, which is why the deal is structured with a senior ranking and anti-dilution ratchet. Note that SPAR's authorized common stock is currently insufficient to cover full conversion, so SPAR must amend its charter by January 31, 2028.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TRAK was trading at $6.33 on NYSE in the Technology sector, with a market capitalization of approximately $115.2M. The 52-week trading range was $6.28 to $15.10. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.